These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2775879)

  • 1. Life forms protectable as subjects of U.S. patents -- microbes to animals (perhaps).
    Hodgins DS
    Biomater Artif Cells Artif Organs; 1989; 17(2):205-24. PubMed ID: 2775879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life forms protectable as subjects of US patents--microbes to animals (perhaps).
    Hodgins DS
    Appl Biochem Biotechnol; 1987; 16():79-93. PubMed ID: 3504131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patentability of genetically engineered microorganisms.
    Cooper A
    JAMA; 1983 Mar; 249(12):1553-4. PubMed ID: 6338261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patents for genetically modified animals.
    O'Connor KW
    J Anim Sci; 1993; 71 Suppl 3():34-40. PubMed ID: 8505268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patentability of Stem Cells in the United States.
    Fendrick SE; Zuhn DL
    Cold Spring Harb Perspect Med; 2015 Aug; 5(12):. PubMed ID: 26292987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harvard v. Canada: the myc mouse that still squeaks in the maze of biopatent law.
    Deftos LJ
    Acad Med; 2001 Jul; 76(7):684-92. PubMed ID: 11448821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent law--patent on life form--man-made modification of microorganism is patentable subject matter under 35 U.S.C. 101--Diamond v. Chakrabarty, 100 S.Ct. 2204 (1980).
    Vidas S
    Hamline Law Rev; 1981 Jan; 4(2):341-50. PubMed ID: 11650724
    [No Abstract]   [Full Text] [Related]  

  • 10. Patent law--man-made, living microorganisms held patentable subject matter under section 101 of the Patent Act--Diamond v. Chakrabarty, 447 U.S. 303 (1980).
    Faggen N
    Temple Law Q; 1981; 54(2):308-30. PubMed ID: 11652407
    [No Abstract]   [Full Text] [Related]  

  • 11. What is your reasonable expectation of success in obtaining pharmaceutical or biotechnology patents having nonobvious claimed inventions that the courts will uphold? An overview of obviousness court decisions.
    Pereira DJ; Kunin SG
    Cold Spring Harb Perspect Med; 2014 Dec; 5(4):. PubMed ID: 25475106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patents for life forms: an inappropriate response to biotechnological advancement.
    Densberger JE
    J Bioeth; 1984; 5(2):91-115. PubMed ID: 11649700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patenting a living microbial cell: 40th anniversary of US Supreme Court decision Diamond versus Chakrabarty.
    Silver S
    FEMS Microbiol Lett; 2020 Jul; 367(13):. PubMed ID: 32501475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent law: live, human-made microorganisms are patentable subject matter under 35 U.S.C. Sect. 101--Diamond v. Chakrabarty.
    Namei FT
    Univ Cincinnati Law Rev; 1980; 49(4):902-13. PubMed ID: 11650489
    [No Abstract]   [Full Text] [Related]  

  • 15. The Impact of Myriad on the Future Development and Commercialization of DNA-Based Therapies and Diagnostics.
    Wales M; Cartier E
    Cold Spring Harb Perspect Med; 2015 Sep; 5(12):. PubMed ID: 26337114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patentability of self-replicating technologies.
    Shear RH
    Cold Spring Harb Perspect Med; 2014 Sep; 5(1):a021071. PubMed ID: 25256175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions.
    Pillai X; Kinney WA
    Curr Top Med Chem; 2010; 10(18):1929-36. PubMed ID: 20615184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell patents--reexamination/litigation--the last 5 years.
    Shyntum Y; Kalkreuter E
    Tissue Eng Part B Rev; 2009 Mar; 15(1):87-90. PubMed ID: 19260807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent law--human-made, genetically engineered, living microorganism constitutes a "manufacture" or "composition of matter" under Title 35 U.S.C. Sect. 101--Diamond v. Chakrabarty, 477 U.S. 303 (1980).
    Harris RR
    Miss Coll Law Rev; 1981 Jan; 2(2):161-73. PubMed ID: 11652412
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?
    Komatani TS
    Pharm Pat Anal; 2015; 4(5):357-62. PubMed ID: 26451906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.